التداخل بين رابيبرازول ووارفارين

Use with Warfarin : Monitor for increases in INR and prothrombin time ( 5.2 , 7 ).

There have been reports of increased INR and prothrombin time in patients receiving a proton pump inhibitor and warfarin concomitantly.

Patients treated with ACIPHEX delayed-release tablets and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time [see Drug Interactions (7) ] .

Warfarin Clinical Impact: Increased INR and prothrombin time in patients receiving PPIs, including rabeprazole, and warfarin concomitantly.

Dose adjustment of warfarin may be needed to maintain target INR range.